Search

everythinglearnresearchcommunity

for

Search:↓

CBD may improve skin and hair health, but its effective use and safety need more research.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

People with alopecia areata have higher insulin resistance.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Gut bacteria differences may help diagnose and treat Alopecia areata.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.